J. Jacobson, B. Sleebs, K. Jarman, W. Nguyen, T. Mota, L. Harty, . . . D.F.J. Purcell. (2017). 4 New HIV specific latency reversing agents with novel targets that synergise with HIV Tat and the bromodomain inhibitor, JQ1 to reactivate HIV from primary cells. Elsevier.
Chicago Style (17th ed.) CitationJ. Jacobson, et al. 4 New HIV Specific Latency Reversing Agents with Novel Targets That Synergise with HIV Tat and the Bromodomain Inhibitor, JQ1 to Reactivate HIV from Primary Cells. Elsevier, 2017.
MLA (9th ed.) CitationJ. Jacobson, et al. 4 New HIV Specific Latency Reversing Agents with Novel Targets That Synergise with HIV Tat and the Bromodomain Inhibitor, JQ1 to Reactivate HIV from Primary Cells. Elsevier, 2017.
Warning: These citations may not always be 100% accurate.